First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
Abroad (travel likely)RecruitingPHASE1
Conditions
R/R AML · R/R HR-MDS · Acute Myeloid Leukemia · Higher-Risk Myelodysplastic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aarhus Universitetshospital - Skejby, Aarhus, Denmark
Copenhagen Rigshospitalet, Copenhagen, Denmark
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital Clínic de Barcelona, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitari i Politècnic La Fe, Valencia, Spain
Study leads
Study Official
Study Director
Genmab